Architecting the Strategic Infrastructure for Global Biopharmaceutical Scaling.
In the complex ecosystem of life sciences, corporate functions are no longer "back-office" supports; they are the enabling pillars of enterprise value. The most effective biopharma teams are those that dismantle the "silo" mentality, integrating HR, IT, and Finance directly into the R&D and commercial roadmap.
At Livasyst, we specialize in identifying the architects of this infrastructure from Senior Managers to CHROs and CTOs -who possess the technical depth to manage IP portfolios and the strategic foresight to lead digital transformations. We understand that in an industry facing a US$236 billion "patent cliff," your corporate leadership must be as innovative as your science. We source "A-player" executives capable of navigating high-stakes organizational design, global regulatory compliance, and the scaling of Global Capability Centers (GCCs) through integrated technology.
Strategic oversight for 200+ specialized senior corporate leadership mandates
Direct access to a vetted ecosystem of 2500+ global finance, tech, and people leaders
95%+ placement rate for hard-to-fill C-suite and VP-level enabling functions
Strategic Leadership for the Enterprise Backbone
Strategic talent architects who drive organizational design, mitigate human capital risk, and foster a "Quality as Responsibility" culture across global sites.
Visionaries who manage the convergence of biology and technology, overseeing AI-driven discovery platforms, cloud-native R&D infrastructure, and cyber-resilient GxP systems.
Strategic P&L owners responsible for capital allocation, M&A integration, and financial planning tailored to the long-cycle risks of drug development.
Guardians of the firm’s "license to operate," managing complex IP landscapes, global litigation strategy, and adherence to GxP/HIPAA standards.
Operational leaders who transform Global Capability Centers into high-maturity innovation hubs that co-own global pipelines and outcomes.
Architects of resilient, net-zero global supply chains who ensure the seamless flow of APIs and clinical materials across borders.
A Methodology Rooted in Organizational Intelligence
We begin by analyzing your firm’s digital maturity and strategic gaps to define a leadership profile that aligns with your 5-year growth horizon.
Discreetly identifying passive leaders from global hubs - from the Boston-Cambridge nexus to the tech clusters of Bengaluru to San Francisco - who have successfully scaled life science enterprises.
Evaluating a candidate’s ability to "influence without authority," assessing how their infrastructure decisions ripple across R&D, Clinical, and Commercial domains.
Testing for "systems thinking" - the ability to lead through the ambiguity of patent expirations, geopolitical shifts, and rapid AI integration.
Facilitating complex negotiations with real-time data on executive compensation, equity structures, and retention bonuses for hybrid talent.
Onboarding support focused on aligning corporate leaders with the scientific mission, ensuring they are mission-ready from day one.
Our Unique Advantages in Corporate Recruitment
Informed by the "Campbell Framework," we vet leaders who understand how infrastructure performance directly impacts R&D productivity.
Livasyst utilizes proprietary talent technology to provide a data-driven vetting process, ensuring that your backbone is built on proven performance, not just credentials.
We excel at sourcing leaders who can build "Twin" headquarters in emerging markets, driving end-to-end value creation rather than mere cost-arbitrage.
From bioinformatics to ERP reporting, we identify leaders fluent in Veeva, IQVIA, and AI-powered analytics etc. technologies who can future-proof your digital operations.
Let’s discuss your firm’s infrastructure leadership needs and how Livasyst can help you identify the executives who will turn your organizational strategy into clinical and commercial reality.
Start Your Search